Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

A mix of sulforaphane, L-menthol, and dexpanthenol could help increase hair growth and reduce hair loss.

Necrosulfonamide helps hair grow by blocking a protein linked to hair loss.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Male pattern baldness is linked to specific genetic variations in the androgen receptor gene.

Sebocytes play a key role in controlling androgen levels in human skin.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Finasteride safely lowers DHT levels without affecting testosterone.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.